Publications and Academic Initiatives
Publications Office
The Yale Cardiovascular Research Group Publications Office is designed to facilitate the complete, ethical, and timely dissemination of clinical research results through high-impact peer-reviewed publications and podium presentations. The YCRG Publications Office facilitates structured collaboration between study investigators, committee members, and sponsors, while providing a scientifically independent resource to guide the creation and execution of a strategic publication plan.
JSCAI
Dr. Alexandra J. Lansky serves as editor in chief of JSCAI, the peer-reviewed, international, Gold Open Access official journal of the Society for Cardiovascular Angiography & Interventions. JSCAI covers all interventional cardiology subspecialities including coronary, peripheral, structural, and congenital heart disease. Dr. Lansky and Executive Editor Dominic Francese collaborate with the editorial board, SCAI staff, and Elsevier to publish high-impact science for the interventional cardiology community.
Academic Initiatives
The Yale Cardiovascular Research Group promotes academic initiatives to inform clinical practice guidelines and the design of future clinical trials. In collaboration with faculty members and industry partners, YCRG conducts systematic reviews and meta-analyses of published clinical trial data and individual participant data in various areas of cardiovascular medicine to assess the safety and performance of cardiovascular devices and neurologic risk associated with these interventions.
Recent Publications
2024
- Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis.Jhand AS, Abusnina W, Tak HJ, Ahmed A, Ismayl M, Altin SE, Sherwood MW, Alexander JH, Rao SV, Abbott JD, Carson JL, Goldsweig AM. Int J Cardiol. 2024 Aug 1; 2024 Apr 30. PMID: 38697401.
- Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice.Bharadwaj AS, Truesdell AG, Lemor A, Thompson JB, Abu-Much A, Zhang Y, Schonning MJ, Cohen DJ, Lansky AJ, O'Neill WW. Am J Cardiol. 2024 Jul 1; 2024 Apr 27. PMID: 38679222.
- Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster M 3rd, Fischell TA, Parise H, Mahfoud F. Circulation. 2024 Jun 11; 2024 Apr 8. PMID: 38587557.
- Statistical considerations for cardiovascular clinical trials straddling the continuum of pandemic phases.White R, Lam P, Lu N, Su X, Bergemann T, Johnson T, Stephens D, Farb A, Jaff M, Lansky A, Kirtane A, Rymer J, Krucoff M. Cardiovasc Revasc Med. 2024 Jun 8; 2024 Jun 8. PMID: 38897847.
- Co-Morbidity Differences Associated With Long-Term Amputation and Repeat Revascularization Rates After Femoropopliteal Artery Intervention for Intermittent Claudication by Gender, Race, and Ethnicity.Altin SE, Parise H, Hess CN, Rosenthal NA, Julien HM, Curtis JP. Am J Cardiol. 2024 Jun 2; 2024 Jun 2. PMID: 38834142.
- Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment.Tannu M, Hess CN, Gutierrez JA, Lopes R, Swaminathan RV, Altin SE, Rao SV. Curr Cardiol Rep. 2024 Jun; 2024 May 14. PMID: 38743352.
- Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.Heuts S, Gabrio A, Veenstra L, Maesen B, Kats S, Maessen JG, Walton AS, Nanayakkara S, Lansky AJ, van 't Hof AWJ, Vriesendorp PA. Heart. 2024 May 10; 2024 May 10. PMID: 37996242.
- A Novel Sirolimus-Coated Balloon for the Treatment of Femoropopliteal Lesions: The SELUTION SFA Japan Trial.Iida O, Soga Y, Saito S, Mano T, Hayakawa N, Ichihashi S, Kawasaki D, Suzuki K, Yamaoka T, Fujihara M, Nakama T, Nakamura M, Horie K, Shah T, Lansky A, Kozuki A. JACC Cardiovasc Interv. 2024 May 8; 2024 May 8. PMID: 38842992.
- Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention?Fezzi S, Ding D, Mahfoud F, Huang J, Lansky AJ, Tu S, Wijns W. Nat Rev Cardiol. 2024 May 7; 2024 May 7. PMID: 38710772.
- Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.Bharadwaj AS, Abu-Much A, Maini AS, Zhou Z, Li Y, Batchelor WB, Grines CL, Baron SJ, Redfors B, Lansky AJ, Basir MB, O'Neill WW. Circ Cardiovasc Interv. 2024 May 6; 2024 May 6. PMID: 38708609.
- Long-Term Percutaneous Coronary Intervention Outcomes in Chronic Versus Acute Coronary Syndromes (TARGET All Comers Trial).Patel KP, Lansky AJ, Kelbæk H, Xu B, van Royen N, Johnson TW, Anderson R, Wijns W, Baumbach A. Am J Cardiol. 2024 Apr 15; 2024 Feb 11. PMID: 38350507.
- Long-term safety and effectiveness of the Fantom bioresorbable coronary artery scaffold: final results of the FANTOM II trial.Lutz M, Abizaid A, Nielsen Holck E, Lansky A, Carrié D, Weber-Albers J, Dudek D, Frey N, Christiansen EH, Holm NR, Stone GW. EuroIntervention. 2024 Apr 1; 2024 Apr 1. PMID: 38562069.
- Addressing Barriers to Entry and Retention of Women in Interventional Vascular Specialties With Proposed Solutions: A Scientific Statement From the American Heart Association.Altin SE, Kwong M, Hamburg NM, Creager MA, Banerjee S, Oladini L, Schneider MD, Ruddy JM. Circulation. 2024 Mar 19; 2024 Feb 20. PMID: 38375663.
- Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI.Abu-Much A, Grines CL, Batchelor WB, Maini AS, Zhang Y, Redfors B, Bellumkonda L, Bharadwaj AS, Moses JW, Truesdell AG, Li Y, Baron SJ, Lansky AJ, Basir MB, Cohen DJ, O'Neill WW. Am Heart J. 2024 Mar; 2023 Dec 26. PMID: 38151142.
- Impact of sex on Transcatheter aortic valve replacement outcomes: Results of a single-center study.See C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Francese DP, Kaple RK, Cleman M, Lansky AJ, Forrest JK. Int J Cardiol. 2024 Mar 1; 2023 Dec 6. PMID: 38065329.
- Anatomic patterns in claudicants who fail supervised exercise therapy.Breen TJ, McGinigle K, Strosberg D, Dardik A, Altin SE. J Vasc Surg. 2024 Mar; 2023 Nov 19. PMID: 37984757.
- Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock Stage.Hanson ID, Rusia A, Palomo A, Tawney A, Pow T, Dixon SR, Meraj P, Sievers E, Johnson M, Wohns D, Ali O, Kapur NK, Grines C, Burkhoff D, Anderson M, Lansky A, Naidu SS, Basir MB, O'Neill W. J Am Heart Assoc. 2024 Feb 6; 2024 Jan 31. PMID: 38293995.
- Sex-specific analysis of intravascular lithotripsy for peripheral artery disease from the Disrupt PAD III observational study.Nagpal S, Altin SE, McGinigle K, Mangalmurti SS, Adams G, Shammas NW, Mehrle A, Soukas P, Bertolet B, Lansky AJ. J Vasc Surg. 2024 Feb; 2023 Nov 2. PMID: 37925039.
- The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually.Foley M, Rajkumar CA, Ahmed-Jushuf F, Nour D, Fung CH, Seligman H, Pathimagaraj RH, Petraco R, Sen S, Nijjer S, Howard JP, Ahmad Y, Allahwala U, Bhindi R, Chamie D, Doi S, Kuwata S, Kaihara T, Koga M, Ishibashi Y, Higuma T, Tanabe Y, Nakayama M, Kawase Y, Watanabe A, Funayama N, Horinaka R, Hijikata N, Takahashi T, Matsuo H, Hansen PS, Manica A, Weaver J, Alzuhairi K, Yong TH, Warisawa T, Francis DP, Shun-Shin MJ, Al-Lamee RK. Cardiovasc Revasc Med. 2024 Feb; 2023 Aug 12. PMID: 37612169.
- Effect of antecedent statin usage on conduction disturbances and arrhythmias after transcatheter aortic valve replacement.Shah T, Maarek R, See C, Huang H, Wang Y, Parise H, Forrest JK, Lansky AJ. Cardiovasc Revasc Med. 2024 Feb; 2023 Jul 27. PMID: 37573173.
- Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation.Omerovic E, Petrie M, Redfors B, Fremes S, Murphy G, Marquis-Gravel G, Lansky A, Velazquez E, Perera D, Reid C, Smith J, van der Meer P, Lipsic E, Juni P, McMurray J, Bauersachs J, Køber L, Rouleau JL, Doenst T. Trials. 2024 Jan 23; 2024 Jan 23. PMID: 38263138.
- Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Trials.Sreenivasan J, Reddy RK, Jamil Y, Malik A, Chamie D, Howard JP, Nanna MG, Mintz GS, Maehara A, Ali ZA, Moses JW, Chen SL, Chieffo A, Colombo A, Leon MB, Lansky AJ, Ahmad Y. J Am Heart Assoc. 2024 Jan 16; 2024 Jan 12. PMID: 38214263.
- Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review.Bikdeli B, Sadeghipour P, Lou J, Bejjani A, Khairani CD, Rashedi S, Lookstein R, Lansky A, Vedantham S, Sobieszczyk P, Mena-Hurtado C, Aghayev A, Henke P, Mehdipoor G, Tufano A, Chatterjee S, Middeldorp S, Wasan S, Bashir R, Lang IM, Shishehbor MH, Gerhard-Herman M, Giri J, Menard MT, Parikh SA, Mazzolai L, Moores L, Monreal M, Jimenez D, Goldhaber SZ, Krumholz HM, Piazza G. Semin Thromb Hemost. 2024 Jan 4; 2024 Jan 4. PMID: 38176425.
- Approval, Evidence, and "Off-Label" Device Utilization: The Patent Foramen Ovale Closure Story.Goldsweig AM, Deng Y, Yao X, Desai NR, Cohen DJ, Aronow HD, Messé SR, Ross JS, Lansky AJ, Savitz ST. Circ Cardiovasc Qual Outcomes. 2024 Jan; 2024 Jan 8. PMID: 38189127.
2023
- Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trial.Lansky AJ, Xu B, Baumbach A, Kelbæk H, van Royen N, Zheng M, Knaapen P, Slagboom T, Johnson TW, Vlachojannis GJ, Arkenbout KE, Holmvang L, Janssens L, Brugaletta S, Naber CK, Schmitz T, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina CM, Buszman PE, Thiele H, Schächinger V, Wijns W. EuroIntervention. 2023 Dec 4; 2023 Dec 4. PMID: 37860860.